Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Обзорная статья

Reactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion

Andromachi KotsaftiLaboratory of Advanced Translational Research, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, ItalyMarco ScarpaGeneral Surgery Unit, Azienda Ospedaliera di Padova, 35128 Padua, ItalyIgnazio CastagliuoloDepartment of Molecular Medicine DMM, University of Padua, 35121 Padua, ItalyMelania ScarpaGeneral Surgery Unit, Azienda Ospedaliera di Padova, 35128 Padua, Italy
2020en
ABI

Аннотация

The immune system is a crucial regulator of tumor biology with the capacity to support or inhibit cancer development, growth, invasion and metastasis. Emerging evidence show that reactive oxygen species (ROS) are not only mediators of oxidative stress but also players of immune regulation in tumor development. This review intends to discuss the mechanism by which ROS can affect the anti-tumor immune response, with particular emphasis on their role on cancer antigenicity, immunogenicity and shaping of the tumor immune microenvironment. Given the complex role that ROS play in the dynamics of cancer-immune cell interaction, further investigation is needed for the development of effective strategies combining ROS manipulation and immunotherapies for cancer treatment.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0